RegeneRx Biopharmaceuticals' IPO

RegeneRx Biopharmaceuticals raised a round of funding on March 27, 2006. Investors include Public.

RegeneRx is a publicly traded, clinical-stage, biopharmaceutical company engaged in the design, research and development of novel peptides targeted at diseases with unmet medical needs. RegeneRx's mis…

Articles about RegeneRx Biopharmaceuticals' IPO: